At Pittcon, FTMS Enters Proteomics: Thermo, Bruker Launch Instruments | GenomeWeb

Proteomics grabbed the spotlight on the vast stage at the Pittcon conference in Orlando, Fla., last week. Not only did the 23,000-plus attendees have a chance to listen to plenary and special lectures by pioneers of protein mass spectrometry techniques — Nobel Laureate John Fenn and Fourier Transform mass spectrometry guru Fred McLafferty — but a number of companies chose the 15-football field-wide exhibition space at the Orange County Convention Center to be the launch pad for their proteomics products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.